AYER, MA, Alcyone Lifesciences has raised $1.8 million in its first round of venture capital, the company disclosed in a regulatory filing.
Alcyone Lifesciences has raised $1.8 million in its first round of venture capital, the company disclosed in a regulatory filing. 14 investors participated in the offering. A principal of MPM Capital is a Co-Founder of the company.
Alcyone is focused on developing products for treatment of difficult and chronic neuropathological conditions.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
